Phase II Drug Metabolism and Individualized Drug Therapy: A Focus on Functional Genetic Variation in UDP-Glucuronosyltransferases

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|8|2|146-166

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.8, Iss.2, 2010-06, pp. : 146-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Roles of UDP-Glucuronosyltransferases in Phytochemical Metabolism of Herbal Medicines and the Associated Herb-Drug Interactions

By  

Current Drug Metabolism, Vol. 13, Iss. 5, 2012-05 ,pp. : 615-623

Bentham Science Publishers

Access to resources Recommend Favorite

Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism

By Jones Drew R.   Moran Jeffery H.   Miller Grover P.  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 55-61

Informa Healthcare

Access to resources Recommend Favorite

UDP-Glucuronosyltransferases

By  

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-01 ,pp. : 143-161

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Metabolism and Individualized Medicine

By  

Current Drug Metabolism, Vol. 4, Iss. 1, 2003-01 ,pp. : 33-44

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Variation of Human UDP-Glucuronosyltransferase: Implications in Disease and Drug Glucuronidation

By Burchell B.  

American Journal of PharmacoGenomics, Vol. 3, Iss. 1, 2003-01 ,pp. : 37-52

Adis International

Access to resources Recommend Favorite